FDA NDC Directory · JSON-LD · Markdown

Rabeprazole Sodium

NDC 76420-107 · HUMAN PRESCRIPTION DRUG · TABLET, DELAYED RELEASE

Labeler / ManufacturerAsclemed USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA205761
Dosage form / routeTABLET, DELAYED RELEASE · ORAL
Active ingredientsRABEPRAZOLE SODIUM (20 mg/1)
Marketing started20170217
Package count3

External sources

Source: openFDA. Public-domain (CC0).